Publications

5674 Results

Alternated and syncopated CHOP-CVB. A test of the Goldie-Coldmanhypothesis by the Southwest Oncology Group.

Authors
L Dabich;MK Liepman;AF LoBuglio;BK Schnitzer;S Dahlberg;PN Grozea;JW Athens;RP Pugh
Journal / Conference
ASCO :#C-810
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8112

Southwest Oncology Group (SWOG) trial: VM-26 and ifosfamide (IF)in refractory adult lymphocytic leukemia (ALL).

Authors
DH Ryan;KJ Kopecky;CH Gumbart;JN Bickers
Journal / Conference
ASCO :#C-561
Year
1987
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8243

Concurrent chemoradiotherapy for limited small cell carcinoma ofthe lung (SCCL).

Authors
JD McCracken;L Janaki;SA Taylor;GB Weiss;J Crowley
Journal / Conference
ASCO :#C-656
Year
1987
Research Committee(s)
Lung
Study Number(s)
SWOG-8269

Concommitant chemo radiotherapy in limited small cell carcinomaof lung: Improved response and median survival. A Southwest OncologyGroup Study.

Authors
LM Janaki;JD McCracken;SB Taylor;PGS Giri;GB Weiss;W Gordon, Jr;RB Vance;J Crowley
Journal / Conference
Presented at the 29th Annual ASTRO Meeting in Boston October 18-23
Year
1987
Research Committee(s)
Lung
Study Number(s)
SWOG-8269

A randomized intergroup trial of adjuvant doxorubicin (DOX) for soft tissue sarcomas (STS): Lack of apparent difference between treatment groups.

Authors
K Antman;D Amato;M Pilepich;H Lerner;S Balcerzak;E Borden;L Baker
Journal / Conference
ASCO 6:134(525)
Year
1987
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8291, SWOG-8391

Toxicity and hematopoietic reserve following hemibodyirradiation (HBI) and CHOP chemotherapy for non-hodgkin's lymphoma(NHL).

Authors
KM Sullivan;PE Neiman;S Dahlberg;R Rivkin;D Tesh
Journal / Conference
ASCO :#C-770
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8361

Activity and toxicity of CBDCA and CHIP in patients with recurrentand advanced head and neck cancer.

Authors
M Al-Sarraf;J Kish;J Ensley;B Metch;J Rinehart;D Schuller;C Coltman, Jr
Journal / Conference
ASCO :#C-485
Year
1987
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8371

Randomized phase II trials of acivicin (AT-125 NSC 163501) andfludarabine (2-fluoro-ara-AMP, NSC 312887) (2 FLAMP) in recurrentmalignant gliomas.

Authors
S Taylor;HJ Eyre
Journal / Conference
ASCO 6:71 (#275)
Year
1987
Research Committee(s)
Brain
Study Number(s)
SWOG-8400/05

A phase II study of m-BACOD for intermediate and high grademalignant lymphomas (NHL).

Authors
B Dana;S Jones;R Fisher;S Dahlberg;J Knost;S Balcerzak;C Ford;K Lanier;J Files;C Fabian;L White;J Carden;R Belt;C Coltman, Jr
Journal / Conference
ASCO :#C-777
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410

Tamoxifen in the treatment of refracatory meningiomas A SouthwestOncology Group study.

Authors
W Goodwin
Journal / Conference
ASCO 6:70 (#270)
Year
1987
Research Committee(s)
Brain
Study Number(s)
SWOG-8415